Alexandria Real Estate Equities
ARE
#2089
Rank
S$12.46 B
Marketcap
S$71.93
Share price
1.23%
Change (1 day)
-42.70%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -S$1.27 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are S$2.94 Billion. a decrease over its 2024 earnings that were of S$0.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 -S$1.26 Billion-242.13%
2024 S$0.88 B96.11%
2023 S$0.44 B-53.56%
2022 S$0.96 B-3.96%
2021 S$1.00 B-20.26%
2020 S$1.26 B72.88%
2019 S$0.73 B3.11%
2018 S$0.70 B73.54%
2017 S$0.40 B464.88%
2016 S$72.26 M-77.32%
2015 S$0.31 B36.31%
2014 S$0.23 B-10.81%
2013 S$0.26 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$14.98 B-1,297.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$28.45 B-2,373.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.42 B-932.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$12.49 B-1,098.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$1.25 B-200.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.15 B-911.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$0.16 B-113.16%๐Ÿ‡บ๐Ÿ‡ธ USA